References
Le Rhun E, Weller M, Brandsma D, Van den Bent M, de Azambuja E, Henriksson R et al (2017) EANOESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours. Ann Oncol 28(suppl_4):iv84–iv99. https://doi.org/10.1093/annonc/mdx221
Kosmas C, Tsavaris NB, Tsakonas G, Soukouli G, Gassiamis A, Mylonakis N, Karabelis A (2005) Cerebrospinal fluid tumor marker levels in predicting response to treatment and survival of carcinomatous meningitis in patients with advanced breast cancer. Med Sci Monit 11(8):CR398–C401
Azevedo Pereira AE, Fanelli MF, Gimenes DL (2011) Meningeal carcinomatosis in breast cancer: prognostic factors and outcome. J Neurooncol 104(2):565–572. https://doi.org/10.1007/s11060-010-0524-y
Yust-Katz S, Garciarena P, Liu D, Yuan Y, Ibrahim N, Yerushalmi R, Penas-Prado M, Groves MD (2013) Breast cancer and leptomeningeal disease (LMD): hormone receptor status influences time to development of LMD and survival from LMD diagnosis. J Neurooncol 114(2):229–235. https://doi.org/10.1007/s11060-013-1175-6
Funding
No funding was received for this article.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Human and animal participants
This article does not contain any studies with human participants or animal performed by any of the authors.
Rights and permissions
About this article
Cite this article
Riolo, M., Ciusani, E. & Salmaggi, A. A case of unusually long survival after leptomeningeal carcinomatosis diagnosis. J Neurooncol 137, 215–218 (2018). https://doi.org/10.1007/s11060-017-2705-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-017-2705-4